A complete portfolio of hematology solutions including automated analyzers, as well as reagents, calibrators and controls for laboratories with diverse testing volumes. Our offerings are designed to enable your clinical laboratory to be more efficient in today’s changing healthcare environment.
CELL-DYN Ruby
Hematology analyzer with advanced capabilities for mid-volume laboratories.
CELL-DYN Emerald 22 AL
Automated hematology analyzer delivering 5-part differential for low- to mid-volume laboratories.
CELL-DYN Emerald 22
Compact hematology analyzer delivering 5-part differential for low-volume laboratories.
CELL-DYN Emerald
Compact hematology analyzer delivering reliable 3-part differentials for low-volume laboratories.
Access live and on-demand complimentary educational webinars led by prominent doctors, subject matter experts, and Abbott professionals. Gain important insight from industry trends, medical discoveries, health technologies, and much more.
Some of these webinars are accredited for 1.0 continuing education credits (CEU) through PACE and the state of Florida.
Nita Munshi, MD
Professor, Head and Director of Laboratory, Ruby Hall Group of Hospitals (Pune, India)
Sten Westgard, MS
Director of Client Services and Technology, Westgard Quality Control
Don Wright, BS MT (ASCP) SH
Scientific Affairs Manager, Abbott Diagnostics
Larry Smith, PhD, SH (ASCP), HCLD/CC (ABB)
Scientific Affairs Manager, Abbott Diagnostics
Don Wright, BS MT (ASCP) SH
Scientific Affairs Manager, Abbott Diagnostics
Larry Smith, PhD, SH (ASCP), HCLD/CC (ABB)
Scientific Affairs Manager, Abbott Diagnostics
Personalized and relevant educational resources to help keep you informed of the latest hematology laboratory topics, including clinical approaches and technologies. We offer a wide range of courses, case studies, how-to videos and webinars tailored to deliver a unique educational experience.
View detailed illustrations of hematopoiesis, the process by which immature precursor cells develop along their path into mature blood cells; lymphocytes, erythrocytes, leukocytes and thrombocytes.
The Hematology Learning Guide is an overview of blood physiology, red and white blood cells, platelets and abnormalities associated with these cellular components. The guide discusses the tests that are part of automated hematology screening as well as different methodologies used to analyze or calculate the results. It also provides additional information regarding the clinical implications of the test results that may also require additional follow-up testing.
The RBC Indices and Extended RBC Parameters Learning Guide provides an overview of erythropoiesis, review traditional and advanced RBC indices & parameters and their clinical utility, and preanalytical variables and interfering substances affecting RBC count and indices.
The Platelet Counting Guide provides an overview of platelet origin and function. The guide discusses the analytical characteristics of platelet counting methods that are determinant factors for their clinical use. Platelet counts are particularly important for clinical decisions on administering platelet concentrates to patients with thrombocytopenia.
The Body Fluids Learning Guide provides an overview of body fluid types, their composition, methods of analysis and clinical significance in disease diagnosis.
The Quality Control Learning Guide provides basic quality control concepts in the hematology laboratory and how to use basic quality control procedures to ensure the best results from your analyzer.
The Middleware Use and Operation Learning Guide serves as a primer and provides a basic overview of middleware, its use, capabilities and benefits in general laboratory operations, with a focus on applications in Hematology.
Hematology analyzers count and characterize blood cells for the screening and monitoring of disease. Analyzers vary in capabilities, sophistication and detection technologies. Since their invention in the 1950s, automated hematology analyzers have become increasingly sophisticated, allowing more precise and accurate CBC and WBC differential results.
The Complete Blood Count (CBC) is one of the most frequently performed laboratory tests. Many diseases can cause abnormalities in the Red Blood Cell (RBC) count; therefore, RBC concentration, as part of CBC, is frequently used in the diagnostic phase for many conditions and as a screening test. Review the technologies hematology analyzers utilize for counting and measuring volumes of RBCs.
The platelet (PLT) count plays a critical role for the diagnosis, treatment and monitoring of patients with many hematological and non-hematological diseases. Inaccuracy in PLT counting can have significant clinical impact, especially at the transfusion trigger levels. If the PLT count is falsely elevated, it could result in a missed PLT transfusion. On the other hand, if the PLT count is falsely decreased, it may lead to unnecessary PLT transfusion with all the hazards associated with it.
As modern hematology laboratories may use various types of hematology analyzers depending on workload, technical resources, and staff, it is important for the user to understand inter-platform variability. This study has shown negligible inter-platform variability between the three studied instruments; CELL-DYN Emerald 22, CELL-DYN Ruby and CELL-DYN Sapphire, and demonstrated substantial equivalence of hematology results between them.
We are dedicated to helping you achieve, fast, accurate, and cost-effective hematology testing.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
